Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-19-002869

Options or other derivatives

  • See Remarks acquired 182,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GARDNER JASON See Remarks 2019-02-05 Grant or award · Stock Option (Right to Buy) +182,900 182,900 D
Loading xslF345X03/doc4.xml…